etrasimod

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced an encouraging update on etrasimod, its drug candidate for the treatment of autoimmune diseases like ulcerative colitis. What Happened Arena Pharmaceuticals reported topline Phase 2 results from an ongoing trial of etrasimod called OASIS...

Celgene Corporation (NASDAQ: CELG) shares plummeted 10 percent Tuesday evening after the U.S. Food and Drug Administration rejected its New Drug Application for ozanimod in the treatment of relapsing multiple sclerosis. What Happened In a preliminary review, the FDA found that the clinical and...